134 related articles for article (PubMed ID: 35093818)
1. Synthesis and formulation of [
Green MA; Mathias CJ
Appl Radiat Isot; 2022 Apr; 182():110119. PubMed ID: 35093818
[TBL] [Abstract][Full Text] [Related]
2. Production and tumour uptake of [64Cu]Pyruvaldehyde-bis (N4-methylthiosemicarbazone) for PET and/or therapeutic purposes.
Jalilian AR; Rowshanfarzad P; Kamrani YY; Shafaii K; Mirzaii M
Nucl Med Rev Cent East Eur; 2007; 10(1):6-11. PubMed ID: 17694494
[TBL] [Abstract][Full Text] [Related]
3. Species dependence of [64Cu]Cu-Bis(thiosemicarbazone) radiopharmaceutical binding to serum albumins.
Basken NE; Mathias CJ; Lipka AE; Green MA
Nucl Med Biol; 2008 Apr; 35(3):281-6. PubMed ID: 18355683
[TBL] [Abstract][Full Text] [Related]
4. Copper-62-labeled pyruvaldehyde bis(N4-methylthiosemicarbazonato)copper(II): synthesis and evaluation as a positron emission tomography tracer for cerebral and myocardial perfusion.
Green MA; Mathias CJ; Welch MJ; McGuire AH; Perry D; Fernandez-Rubio F; Perlmutter JS; Raichle ME; Bergmann SR
J Nucl Med; 1990 Dec; 31(12):1989-96. PubMed ID: 2266398
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a potential generator-produced PET tracer for cerebral perfusion imaging: single-pass cerebral extraction measurements and imaging with radiolabeled Cu-PTSM.
Mathias CJ; Welch MJ; Raichle ME; Mintun MA; Lich LL; McGuire AH; Zinn KR; John EK; Green MA
J Nucl Med; 1990 Mar; 31(3):351-9. PubMed ID: 2308007
[TBL] [Abstract][Full Text] [Related]
6. Performance of a ⁶²Zn/⁶²Cu microgenerator in kit-based synthesis and delivery of [⁶²Cu]Cu-ETS for PET perfusion imaging.
Ng Y; Lacy JL; Fletcher JW; Green MA
Appl Radiat Isot; 2014 Sep; 91():38-43. PubMed ID: 24886964
[TBL] [Abstract][Full Text] [Related]
7. Species-dependent binding of copper(II) bis(thiosemicarbazone) radiopharmaceuticals to serum albumin.
Mathias CJ; Bergmann SR; Green MA
J Nucl Med; 1995 Aug; 36(8):1451-5. PubMed ID: 7629593
[TBL] [Abstract][Full Text] [Related]
8. Human biodistribution and dosimetry of the PET perfusion agent copper-62-PTSM.
Wallhaus TR; Lacy J; Whang J; Green MA; Nickles RJ; Stone CK
J Nucl Med; 1998 Nov; 39(11):1958-64. PubMed ID: 9829589
[TBL] [Abstract][Full Text] [Related]
9. Copper-62-pyruvaldehyde bis(N-methyl-thiosemicarbazone) PET imaging in the detection of coronary artery disease in humans.
Wallhaus TR; Lacy J; Stewart R; Bianco J; Green MA; Nayak N; Stone CK
J Nucl Cardiol; 2001; 8(1):67-74. PubMed ID: 11182711
[TBL] [Abstract][Full Text] [Related]
10. Comparison of cell-labeling methods with ¹²⁴I-FIAU and ⁶⁴Cu-PTSM for cell tracking using chronic myelogenous leukemia cells expressing HSV1-tk and firefly luciferase.
Park JJ; Lee TS; Son JJ; Chun KS; Song IH; Park YS; Kim KI; Lee YJ; Kang JH
Cancer Biother Radiopharm; 2012 Dec; 27(10):719-28. PubMed ID: 23009582
[TBL] [Abstract][Full Text] [Related]
11. Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects.
Basken NE; Green MA
Nucl Med Biol; 2009 Jul; 36(5):495-504. PubMed ID: 19520290
[TBL] [Abstract][Full Text] [Related]
12. Assessment of regional myocardial and renal blood flow with copper-PTSM and positron emission tomography.
Shelton ME; Green MA; Mathias CJ; Welch MJ; Bergmann SR
Circulation; 1990 Sep; 82(3):990-7. PubMed ID: 2394015
[TBL] [Abstract][Full Text] [Related]
13. Performance of a 62Zn/62Cu generator in clinical trials of PET perfusion agent 62Cu-PTSM.
Haynes NG; Lacy JL; Nayak N; Martin CS; Dai D; Mathias CJ; Green MA
J Nucl Med; 2000 Feb; 41(2):309-14. PubMed ID: 10688116
[TBL] [Abstract][Full Text] [Related]
14. PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
Zhang T; Das SK; Fels DR; Hansen KS; Wong TZ; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2013 Nov; 201(5):W698-706. PubMed ID: 24147499
[TBL] [Abstract][Full Text] [Related]
15. PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
Wong TZ; Lacy JL; Petry NA; Hawk TC; Sporn TA; Dewhirst MW; Vlahovic G
AJR Am J Roentgenol; 2008 Feb; 190(2):427-32. PubMed ID: 18212229
[TBL] [Abstract][Full Text] [Related]
16. Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals.
Basken NE; Mathias CJ; Green MA
J Pharm Sci; 2009 Jun; 98(6):2170-9. PubMed ID: 18937368
[TBL] [Abstract][Full Text] [Related]
17. Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM), a metal complex with selective NADH-dependent reduction by complex I in brain mitochondria: a potential radiopharmaceutical for mitochondria-functional imaging with positron emission tomography (PET).
Taniuchi H; Fujibayashi Y; Okazawa H; Yonekura Y; Konishi J; Yokoyama A
Biol Pharm Bull; 1995 Aug; 18(8):1126-9. PubMed ID: 8535408
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Cu-PTSM as a tracer of tumor perfusion: comparison with labeled microspheres in spontaneous canine neoplasms.
Mathias CJ; Green MA; Morrison WB; Knapp DW
Nucl Med Biol; 1994 Jan; 21(1):83-7. PubMed ID: 9234268
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of copper radiopharmaceuticals with mixed bis(thiosemicarbazone) ligands.
Ackerman LJ; West DX; Mathias CJ; Green MA
Nucl Med Biol; 1999 Jul; 26(5):551-4. PubMed ID: 10473194
[TBL] [Abstract][Full Text] [Related]
20. Copper(II) bis(thiosemicarbazone) complexes as potential tracers for evaluation of cerebral and myocardial blood flow with PET.
Green MA; Klippenstein DL; Tennison JR
J Nucl Med; 1988 Sep; 29(9):1549-57. PubMed ID: 3261785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
